Presumptive COVID-19 Case Results Confirmed Negative

MARY RIVER, NUNAVUT, July 10, 2020 – Baffinland Iron Mines Corporation (“Baffinland” or the “Company”) has received the final analysis of the presumptive employee’s COVID-19 test.  We are pleased to report the results from the government-designated testing facility in Ontario have been confirmed to be negative.

As a result, the individual with presumptive COVID-19 and their contacts have been removed from isolation.

Baffinland’s robust Pandemic Response Plan was in full force and proved to be successful in detecting and managing a presumptive positive case.

The dedicated support from all employees in following the protective measures combined with the GuardRX mobile testing regime at our mine site have greatly assisted in keeping our operations COVID-19 free. Baffinland will continue to adjust their risk management approach to benefit the health and wellbeing of our workforce.

We would like to thank Dr. Michael Patterson, Nunavut Public Health’s Chief Medical Officer, the Public Health Agency of Canada (PHAC) and the territorial government for their guidance and support throughout the management of this presumptive case.

For any media inquiries:
Salima Virani
Interim Communications Lead
Baffinland Iron Mines
T: (365) 292-3848


About Baffinland Iron Mines Corporation
Jointly owned by Nunavut Iron Ore and ArcelorMittal, Baffinland Iron Mines Corporation operates a high-grade iron ore mine located on Baffin Island, Nunavut. Our mine produces the highest grade of direct shipping iron ore in the world. Baffinland has applied for permits to increase annual shipments. Baffinland is committed to operating the Mary River Mine in an environmentally and socially responsible manner that benefits all stakeholders. Learn more at and follow us on Twitter, Facebook and LinkedIn.

ᐹᕙᓐᓛᓐ ᑯ ᑦ  ᓴᕕᕋᔭᒃᓴᓂᒃ ᐅᔭᕋᖕᓂᐊᕐᕕᖏᑕ  ᑯᐊᐳᕇᓴᖓᑦ (“ᐹᕙᓐᓛᓐ”  “ᑲᒻᐸᓂᓘᓐᓃᑦ”)  ᐱᓯᒪᓕᖅᑐᑦ  ᑭᖑᓪᓕᖅᐹᒧᑦ  ᖃᐅᔨᓴᖅᑕᐅᓂᖓ  ᓄᕙᕐᔪᐊᕋᓱᒋᔭᐅᓚᐅᖅᑐᒧᑦ  ᑯᕕᑦ-19ᒧᑦ.   ᐊᓕᐊᓇᐃᒍᓱᒃᐳᒍᑦ  ᐅᖃᐅᓯᕆᔪᓐᓇᕋᑦᑎᒍᑦ  ᖃᐅᔨᔭᐅᔪᑦ  ᒐᕙᒪᓂᑦ  ᑎᓕᔭᐅᓯᒪᔪᓄᑦ  ᖃᐅᔨᓴᕐᕕᖕᒥᑦ  ᐋᓐᑎᐊᕆᐆᒥᑦ  ᓄᕙᕐᔪᐊᖏᒻᒪᑕ.   

ᑕᐃᒪᐃᒻᒪᑦ,  ᓄᕙᕐᔪᐊᕋᓱᒋᔭᐅᓚᐅᖅᑐᖅ  ᑯᕕᑦ-19ᒧᑦ  ᐅᐸᓚᐅᖅᑕᖏᓪᓗ  ᐃᓄᑑᑎᑕᐅᔪᓐᓃᖅᑐᑦ.   

ᐹᕙᓐᓛᓐᑯᑦ  ᓄᕙᕐᔪᐊᕐᓂᕐᒧᑦ  ᖃᓄᐃᒋᐊᕈᑎᕗᑦ  ᐸᕐᓇᐅᑎᕗᑦ  ᐱᓕᕆᑦᑎᐊᓚᐅᖅᐳᖅ  ᑲᔪᓯᑦᑎᐊᖅᖢᓂᓗ  ᖃᐅᔨᓪᓗᑎᒃ  ᐊᐅᓚᑦᑎᓪᓗᑎᒡᓗ  ᓄᕙᕐᔪᐊᕋᓱᒋᔭᐅᔪᕐᒥᒃ. 

ᐃᑲᔪᖅᑐᑦᑎᐊᕐᓂᖏᑦ  ᐃᖅᑲᓇᐃᔭᖅᑎᓕᒫᓂᑦ  ᒪᓕᒃᖢᒋᑦ  ᓴᐳᔾᔪᔾᔭᐅᑕᐅᔪᑦ  ᐃᓚᒋᓪᓗᓂᐅᒡᓗ  ᒐᕐᑦRXᒧᑦ  ᖃᐅᔨᓴᖃᑦᑕᕐᓂᕗᑦ  ᐅᔭᕋᖕᓂᐊᕐᕕᑦᑎᓐᓂ  ᐃᑲᔪᓪᓚᒃᓯᒪᕗᑦ  ᐊᐅᓚᓂᕗᑦ  ᑯᕕᑦ-19ᒧᑦ  ᐊᒃᑐᖅᑕᐅᓇᑎᒃ.  ᐹᕙᓐᓛᓐᑯᑦ  ᑲᔪᓰᓐᓇᕐᓂᐊᖅᐳᑦ  ᐋᖅᑭᒋᐊᖅᐸᒡᓗᒋᑦ  ᐅᓗᕆᐊᓇᖅᑐᓄᑦ  ᐊᐅᓚᔾᔪᓯᖏᑦ  ᐱᕚᓪᓕᖁᓪᓗᒋᑦ  ᖃᓄᐃᖏᓐᓂᖏᑦ  ᐃᖅᑲᓇᐃᔭᖅᑎᑦᑕ.   

ᖁᔭᒋᔪᒪᕙᕗᑦ  ᓘᒃᑖᖅ  ᒪᐃᑯ  ᐹᑐᓴᓐ,  ᓄᓇᕘᒥ  ᐃᓄᓕᒫᓄᑦ  ᖃᓄᐃᖏᓐᓂᕐᓄᑦ  ᓘᒃᑖᓪᓗᐊᑕᖓ,  ᐃᓄᓕᒫᓄᑦ  ᖃᓄᐃᖏᓐᓂᕐᓄᑦ  ᑲᓇᑕᒥᒃᑯᑦ   ᓄᓇᕘᒃᑯᓪᓗ  ᒐᕙᒪᖓᑦ  ᑎᓕᐅᕆᓂᖏᓐᓄᑦ  ᐃᑲᔪᕐᓂᖏᓐᓄᓪᓗ  ᐊᐅᓚᑕᐅᑎᓪᓗᒍ  ᑖᓐᓇ   ᓄᕙᕐᔪᐊᕋᓱᒋᔭᐅᓚᐅᖅᑐᖅ. 

ᐱᕙᓪᓕᐊᔪᓕᕆᔨᓂᑦ  ᑐᓴᕋᓱᒍᒪᔪᑦ
ᓴᓕᒪ  ᕕᕋᓂ
ᒫᓐᓇᐅᔪᖅ  ᑐᓴᐅᒪᑎᑦᑎᓕᕆᔨ 
ᐹᕙᓐᓛᓐ ᑯ ᑦ  ᓴᕕᕋᔭᒃᓴᓂᒃ ᐅᔭᕋᖕᓂᐊᕐᕕᖏᑦ 
T: (365) 292-3848


ᐹᕙᓐᓛᓐ ᑦ  ᓴᕕᕋᔭᒃᓴᓂᒃ ᐅᔭᕋᖕᓂᐊᕐᕕᖏᑕ  ᑯᐊᐳᕇᓴᖓᑦ  
ᑲᑐᔾᔭᐅᓪᓗᓂ  ᓇᖕᒥᓂᕆᔭᐅᔪᖅ  ᓄᓇᕘᒥ  ᓴᕕᕋᔭᒃᓴᓄᑦ  ᐊᓱᓗᒥᑖᓪᑯᓐᓂᑦ,  ᐹᕙᓐᓛᓐ ᑯ ᑦ  ᓴᕕᕋᔭᒃᓴᓂᒃ ᐅᔭᕋᖕᓂᐊᕐᕕᖏᑕ  ᑯᐊᐳᕇᓴᖓᑦ  ᐊᐅᓚᑦᑎᕗᑦ  ᓴᕕᕋᔭᒃᓴᑦᑎᐊᕚᓗᖕᓄᑦ  ᐅᔭᕋᖕᓂᐊᕐᕕᖕᒥᒃ  ᕿᑭᖅᑖᓗᒃ,  ᓄᓇᕘᒥ.  ᐅᔭᕋᖕᓂᐊᕐᕕᕗᑦ  ᐅᔭᕋᖕᓂᐊᖃᑦᑕᖅᐳᖅ  ᐱᐅᓛᒥᒃ  ᐊᐅᓪᓚᐅᔾᔭᐅᑲᐅᑎᒋᔪᒥᒃ  ᓴᕕᕋᔭᒃᓴᒥᒃ  ᓄᓇᕐᔪᐊᕐᒥ. ᐹᕙᓐᓛᓐᑯᑦ  ᐱᓇᓱᒃᓯᒪᕗᑦ  ᐱᔪᓐᓇᐅᑎᓂᒃ  ᐅᓄᖅᓯᒋᐊᕈᒪᓪᓗᒋᑦ  ᐊᕐᕌᒍᑕᒫᑦ  ᐊᐅᓪᓚᐅᓂᓂᕐᒥᓂᒃ. ᐹᕙᓐᓛᓐᑯᑦ  ᐊᖏᖅᓯᒪᕗᑦ  ᐊᐅᓚᑦᑐᒪᓪᓗᒍ  ᓄᓘᔮᖕᓂ  ᐅᔭᕋᖕᓂᐊᕐᕕᒃ  ᐊᕙᑎᑎᒍᑦ ᐃᓅᓯᑎᒍᓪᓗ  ᐱᓕᕆᕆᐊᒃᓴᕆᔭᒥᑎᑐᑦ  ᐱᕚᓪᓕᕈᑕᐅᓗᓂ  ᑎᒍᒥᐊᖃᑕᐅᔪᓕᒫᑦ.  ᐃᓕᒃᑲᓐᓂᕆᑦ  ᐅᕙᓂ  ᐊᒻᒪᓗ ᒪᓕᒃᑎᒍᑦ  Twitter, Facebook  LinkedIn.